Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eudora Lee

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Dermatology Online Journal|December 7, 2024
Pyoderma gangrenosum after breast reduction surgeryEudora Lee, Subin Lim, Erika Elliott, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 24, 2019
Tissue Inhibitor of Metalloproteinase 3 Deficiency Disrupts the Hepatocyte E-Cadherin/β-Catenin Complex and Induces Cell Death in Liver Ischemia/Reperfusion InjuryTakehiro Fujii, Sergio Duarte, Eudora Lee, et al.
Dermatology Practical & Conceptual|May 22, 2025
Diversity Gaps in Clinical Practice Guidelines for Cutaneous Malignancies: A Focus on Melanoma, Basal Cell Carcinoma, and Squamous Cell CarcinomaCourtney A Chau, Subin Lim, Rachel Granovsky, et al.
Journal of the American Academy of Dermatology|June 24, 2026
Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case seriesRalina Karagenova, Eudora Lee, Lirit Fuksman, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse eventsEudora Lee, Ralina Karagenova, Lirit Fuksman, et al.
International Journal of Dermatology|January 16, 2026
Clinicopathologic and Immunohistochemical Features of Enfortumab Vedotin-Induced Cutaneous ToxicityFederico Repetto, Soma Jobbagy, Eudora Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinomaEudora Lee, Ralina Karagenova, Charles Lu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Dermatology Online Journal|December 7, 2024
Pyoderma gangrenosum after breast reduction surgeryEudora Lee, Subin Lim, Erika Elliott, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 24, 2019
Tissue Inhibitor of Metalloproteinase 3 Deficiency Disrupts the Hepatocyte E-Cadherin/β-Catenin Complex and Induces Cell Death in Liver Ischemia/Reperfusion InjuryTakehiro Fujii, Sergio Duarte, Eudora Lee, et al.
Dermatology Practical & Conceptual|May 22, 2025
Diversity Gaps in Clinical Practice Guidelines for Cutaneous Malignancies: A Focus on Melanoma, Basal Cell Carcinoma, and Squamous Cell CarcinomaCourtney A Chau, Subin Lim, Rachel Granovsky, et al.
Journal of the American Academy of Dermatology|June 24, 2026
Nemolizumab for treatment-refractory cutaneous adverse events in patients with cancer: A retrospective multi-institutional case seriesRalina Karagenova, Eudora Lee, Lirit Fuksman, et al.
Journal for Immunotherapy of Cancer|June 19, 2026
Evaluating the safety of Janus kinase inhibitors in the management of severe immune-related adverse eventsEudora Lee, Ralina Karagenova, Lirit Fuksman, et al.
International Journal of Dermatology|January 16, 2026
Clinicopathologic and Immunohistochemical Features of Enfortumab Vedotin-Induced Cutaneous ToxicityFederico Repetto, Soma Jobbagy, Eudora Lee, et al.
Medrxiv : the Preprint Server for Health Sciences|June 4, 2026
Enfortumab vedotin-induced cutaneous toxicities and their association with survival in urothelial carcinomaEudora Lee, Ralina Karagenova, Charles Lu, et al.
Pageof 1